Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease
A dual-action GLP-1/GIP program for patients whose clinician recommends a two-pathway approach
It produces butyrate, a short-chain fatty acid that may help keep the gut barrier strong and support healthy immune function
NEW - Blue Shield will launch three PPO Savings Plans offering expanded weight loss drug coverage in 2027: Full PPO Savings Embedded Deductible 3400 100% with Enhanced+ Rx Full PPO Savings Two-Tier Embedded Deductible 1700/3400/3400 90/60 with Enhanced+ Rx NOTE: Weight loss drugs under these plans are covered with prior authorization for BMI 30 or 27 with certain weight-related conditions, lowering the requirement from the previous BMI of 40
US$ 25.67
US$ 28.96
US$ 26.69
US$ 21.88
US$ 23.94
US$ 21.35
